For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251231:nRSe3303Na&default-theme=true
RNS Number : 3303N Iconic Labs PLC 31 December 2025
31 December 2025
Iconic Labs Plc
("Iconic" or the "Company")
Result of AGM
The Directors of Iconic Labs Plc are pleased to announce that at the Annual
General Meeting of the Company held earlier today, Resolutions 1 to 7 were all
were duly approved by shareholders by way of a poll.
The results of the poll were as follows:
Resolutions For % Against % Withheld
1 To receive and adopt the accounts for the financial year ended 30 June 2025. 1,714,575 99.35% 11,176 0.65% 8,985
2 To re-appoint RPG Chartered Accountants as Auditors. 1,712,111 99.21% 13,640 0.79% 8,985
3 To authorise the Directors to determine the remuneration of the Auditors. 1,710,100 99.21% 13,640 0.79% 10,996
4 To re-appoint Bela Lendvai-Lintner as a Director. 1,680,380 97.45% 43,887 2.55% 10,469
5 To authorise the Directors to allot shares as set out in the Notice of the 1,680,974 97.56% 42,054 2.44% 11,708
meeting.
Special Resolutions:
6 To adopt new Articles of Association 1,686,150 97.82% 37,640 2.18% 10,946
7 To empower the Directors to generally allot relevant equity securities as set 1,681,376 97.57% 41,887 2.43% 11,473
out in the Notice of the meeting.
ENDS
For more information, please contact:
Iconic Labs via Yellow Jersey PR
John Farquharson, Chief Executive Officer
AlbR Capital Limited Tel: +44 (0) 20 7469 0930
Daniel Harris / David Coffman
Yellow Jersey PR Tel: +44 (0) 20 3004 9512
Charles Goodwin iconic@yellowjerseypr.com
Annabelle Wills
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGWPGQWPUPAGGG
Copyright 2019 Regulatory News Service, all rights reserved